移植診断薬市場：製品、技術、移植、用途、エンドユーザー別-2023-2030年の世界予測

移植診断薬の世界市場は、2023年に45億9,778万米ドル、CAGR7.42％で大きく成長し、2030年には驚異的な76億5,300万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の移植診断薬市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.移植診断薬の世界市場規模および予測は？

2.予測期間中、世界の移植診断薬市場を形成するCOVID-19の阻害要因と影響は？

3.移植診断薬の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.移植診断薬の世界市場における競争戦略は？

5.移植診断薬の世界市場における技術動向と規制の枠組みは？

6.移植診断薬の世界市場における主要ベンダーの市場シェアは？

7.移植診断薬の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 臓器提供に対する意識の高まりと臓器移植の増加
    • 移植診断薬の研究開発にさらに重点を置く
    • 新興諸国における医療ツーリズムの成長
  • 抑制要因
    • 臓器移植手術に伴う高額な費用
  • 機会
    • 移植診断薬のテクノロジーの進歩が進む
    • 臓器移植に関する規制ガイドラインの拡大
  • 課題
    • 保険や償還制度の欠如と臓器移植の合併症
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 移植診断薬市場：提供別

• 楽器
• 試薬と消耗品
• ソフトウェアとサービス

第7章 移植診断薬市場：技術別

• 分子アッセイ
• 非分子アッセイ

第8章 移植診断薬市場移植別

• 軟部組織移植
• 固形臓器移植
• 幹細胞移植

第9章 移植診断薬市場：用途別

• 診断アプリケーション
• 調査用途

第10章 移植診断薬市場：エンドユーザー別

• 病院と移植センター
• 独立した基準研究所
• 調査および学術機関

第11章 南北アメリカの移植診断薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の移植診断薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの移植診断薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別
  • 合併・買収
  • 契約、コラボレーション、パートナーシップ
  • 新製品発売と機能強化
  • 受賞・表彰・拡大

第15章 掲載企業一覧

第16章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. TRANSPLANT DIAGNOSTICS MARKET RESEARCH PROCESS
• FIGURE 2. TRANSPLANT DIAGNOSTICS MARKET SIZE, 2022 VS 2030
• FIGURE 3. TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2022 VS 2030 (%)
• FIGURE 5. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
• FIGURE 6. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2022 VS 2030 (%)
• FIGURE 7. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 8. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 9. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 10. TRANSPLANT DIAGNOSTICS MARKET DYNAMICS
• FIGURE 11. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 20. TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 21. TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. TRANSPLANT DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 5. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 9. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NON-MOLECULAR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 12. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOFT TISSUE TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOLID ORGAN TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STEM CELL TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS & TRANSPLANT CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 39. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 41. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 66. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 68. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 71. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 73. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 76. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 81. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 86. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 91. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 96. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 101. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 106. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 111. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 116. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 121. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 122. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 127. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 132. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 137. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 142. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 147. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 152. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 156. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 157. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 159. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 161. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 162. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 166. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 167. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 171. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 172. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 177. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 179. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 181. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 182. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 184. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 187. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 191. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 192. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 193. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 196. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 197. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 198. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 201. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 202. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 203. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 206. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 207. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 208. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 211. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 212. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 213. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 216. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 217. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 218. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 221. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 222. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 223. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 226. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 227. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 228. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 231. TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 232. TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 233. TRANSPLANT DIAGNOSTICS MARKET LICENSE & PRICING

The Global Transplant Diagnostics Market is forecasted to grow significantly, with a projected USD 4,597.78 million in 2023 at a CAGR of 7.42% and expected to reach a staggering USD 7,653.00 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Transplant Diagnostics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Transplant Diagnostics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Offering, market is studied across Instruments, Reagents & Consumables, and Software & Services. The Reagents & Consumables commanded largest market share of 43.67% in 2022, followed by Instruments.

Based on Technology, market is studied across Molecular Assays and Non-Molecular Assays. The Molecular Assays commanded largest market share of 53.43% in 2022, followed by Non-Molecular Assays.

Based on Transplant, market is studied across Soft Tissue Transplant, Solid Organ Transplant, and Stem Cell Transplant. The Soft Tissue Transplant commanded largest market share of 45.14% in 2022, followed by Stem Cell Transplant.

Based on Application, market is studied across Diagnostic Applications and Research Applications. The Research Applications commanded largest market share of 67.38% in 2022, followed by Diagnostic Applications.

Based on End User, market is studied across Hospitals & Transplant Centers, Independent Reference Laboratories, and Research Laboratories & Academic Institutes. The Hospitals & Transplant Centers commanded largest market share of 47.86% in 2022, followed by Research Laboratories & Academic Institutes.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 42.12% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Transplant Diagnostics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Transplant Diagnostics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Transplant Diagnostics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Transplant Diagnostics Market?

4. What is the competitive strategic window for opportunities in the Global Transplant Diagnostics Market?

5. What are the technology trends and regulatory frameworks in the Global Transplant Diagnostics Market?

6. What is the market share of the leading vendors in the Global Transplant Diagnostics Market?

7. What modes and strategic moves are considered suitable for entering the Global Transplant Diagnostics Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Transplant Diagnostics Market, by Offering, 2022 vs 2030
• 4.3. Transplant Diagnostics Market, by Technology, 2022 vs 2030
• 4.4. Transplant Diagnostics Market, by Transplant, 2022 vs 2030
• 4.5. Transplant Diagnostics Market, by Application, 2022 vs 2030
• 4.6. Transplant Diagnostics Market, by End User, 2022 vs 2030
• 4.7. Transplant Diagnostics Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing awareness for organ donation and rise in organ transplant
    • 5.1.1.2. Increased focus on research & development of transplant diagnostics
    • 5.1.1.3. Growing medical tourism in developing countries
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with organ transplant procedures
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing technological advancements in transplant diagnostics
    • 5.1.3.2. Growing regulatory guidelines for organ transplant
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of insurance and reimbursement policies and complications of organ transplant
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Transplant Diagnostics Market, by Offering

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Reagents & Consumables
• 6.4. Software & Services

7. Transplant Diagnostics Market, by Technology

• 7.1. Introduction
• 7.2. Molecular Assays
• 7.3. Non-Molecular Assays

8. Transplant Diagnostics Market, by Transplant

• 8.1. Introduction
• 8.2. Soft Tissue Transplant
• 8.3. Solid Organ Transplant
• 8.4. Stem Cell Transplant

9. Transplant Diagnostics Market, by Application

• 9.1. Introduction
• 9.2. Diagnostic Applications
• 9.3. Research Applications

10. Transplant Diagnostics Market, by End User

• 10.1. Introduction
• 10.2. Hospitals & Transplant Centers
• 10.3. Independent Reference Laboratories
• 10.4. Research Laboratories & Academic Institutes

11. Americas Transplant Diagnostics Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Transplant Diagnostics Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Transplant Diagnostics Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. FPNV Positioning Matrix
• 14.2. Market Share Analysis, By Key Player
• 14.3. Competitive Scenario Analysis, By Key Player
  • 14.3.1. Merger & Acquisition
    • 14.3.1.1. Werfen to acquire transfusion and transplant diagnostics innovator for around USD 2 billion
    • 14.3.1.2. Thermo Fisher will buy the binding site for $2.6B to gain specialty diagnostics portfolio
    • 14.3.1.3. GenDx to develop NGS-Turbo following agreement with Oxford Nanopore Technologies
    • 14.3.1.4. Eurobio Scientific buys Dutch transplant diagnostics firm GenDx for €135 million
  • 14.3.2. Agreement, Collaboration, & Partnership
    • 14.3.2.1. Immucor and Pirche announce multi-year partnership
  • 14.3.3. New Product Launch & Enhancement
    • 14.3.3.1. Quest Diagnostics unveils advanced transplant diagnostic services featuring anywhere-access in the United States
    • 14.3.3.2. Eurofins Scientific SE: Transplant Genomics announces the launch of Trugraf Liver, the first and only non-invasive gene expression diagnostic test to optimize immunosuppression in liver transplant recipients
    • 14.3.3.3. Immucor announces innovations in transplant diagnostics
  • 14.3.4. Award, Recognition, & Expansion
    • 14.3.4.1. Plexision launches personalized transplant diagnostic testing in India
    • 14.3.4.2. Eurofins Viracor opens expansive laboratory in Lenexa, KS
    • 14.3.4.3. Hologic announces FDA approval of Aptima CMV Quant Assay For Human Cytomegalovirus

15. List of Company Mentioned

16. Appendix

• 16.1. Discussion Guide
• 16.2. License & Pricing